Concepedia

Igor Kišš

IK

Statistics

Publications

45

Citations

2.2K

H-Index

23

Active since

2007

Affiliations

Masaryk Memorial Cancer Institute(Current)

Masaryk University

Central European Institute of Technology

Palacký University Olomouc

Charles University

Igor Kišš is an author at Masaryk Memorial Cancer Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2007–2023

45

Publications

45

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 439 citations · Full text

, , +11

Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer

Petra Vychytilova‐Faltejskova, Lenka Radová, Milana Šachlová et al. · Carcinogenesis · 2016 · 164 citations · Full text

, , +17

Identification and functional screening of micro<scp>RNA</scp>s highly deregulated in colorectal cancer

Petra Faltejsková, Marek Svoboda, Klára Šrůtová et al. · Journal of Cellular and Molecular Medicine · 2012 · 133 citations · Full text

, , +17

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

Petra Vychytilova‐Faltejskova, Jana Merhautová, Táňa Macháčková et al. · Oncogenesis · 2017 · 102 citations · Full text

, , +17

Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer

Petra Vychytilova‐Faltejskova, Karolína Štítkovcová, Lenka Radová et al. · Cancer Epidemiology Biomarkers & Prevention · 2018 · 102 citations · Full text

, , +17

1–5 of 45